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Phosphorylation of fibronectin was studied in quiescent vs growing cells from several species. Fibronectin 
secreted by actively growing cells exhibits a significantly higher level of phosphorylation than does the 
fibronectin secreted by quiescent cells of the same species. 
Fibronectin Phosphorylation Growing vs. quiescent cells 
1. INTRODUCTION 
Fibronectin, a high M, glycoprotein present on 
the surfaces of various cell types and also in blood 
plasma, is important for several biological func- 
tions [l-4]. A role for fibronectin has been sug- 
gested in a wide variety of cellular activities such as 
cell-to-cell and cell-to-substratum adhesion [5-71, 
cell shape formation and cellular migration [8,9], 
organization of intracellular cytoskeletal elements 
and extracellular matrix [lO,ll], reticuloendothelial 
clearance of foreign particles [12] and embryo- 
genesis and differentiation [ 13- 151. 
The amount of cell surface fibronectin is usually 
very much decreased on cultured tumor cells and in 
cells transformed in vitro with oncogenic viruses or 
by chemical carcinogens [l-4]. Compared to non- 
proliferating quiescent cells fibronectin is present in 
reduced amounts on the surfaces of rapidly growing 
and mitotic cells [16,17]. This may not be sur- 
prising in view of the fact that rapidly growing and 
mitotic cells exhibit several biochemical changes 
that are typical of transformed cells [18,19]. 
Fibronectin from transformed cells is phosphory- 
lated to a much higher extent than that from nor- 
mal cells [20]. Since the functions of a variety of 
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enzymes and other proteins are regulated by phos- 
phorylation, it was of interest o study phosphory- 
lation of fibronectin produced by quiescent and 
growing cells. 
2. MATERIALS AND METHODS 
2.1. Cells 
Human skin fibroblasts, GMO077, obtained 
from the Institute For Medical Research (Camden, 
NJ) and a mouse fibroblast line, NIH/3T3, were 
grown in Dulbecco’s modified Eagle’s Medium 
(DMEM) containing 10% fetal calf serum (FCS). 
The hamster cell line, NIL-8, was grown in 
DMEM + 5% FCS. 
2.2. Radioactive labeling 
Monolayers of either quiescent or rapidly 
growing cells, which were 50% confluent, were 
labeled with [32P] orthophosphate (500 &i/ml; 
carrier-free; New England Nuclear) and [3H]leucine 
(100 &i/ml; 100 Ci/ml; New England Nuclear) in 
medium lacking phosphate and leucine, plus 5% 
dialyzed FCS. 
2.3. Isolation of jiibronectin 
Fibronectin was isolated from the labeled condi- 
tioned medium of NIL 8 cells and NIH/3T3 fibro- 
blasts by 2 cycles of immunoprecipitation using 
antihamster fibronectin serum as in [20]. Mono- 
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clonal antibodies designated as 3E3 [21] were used 
to precipitate the fibronectin from the conditioned 
medium of GM0077 cells. 
SDS-polyacrylamide gel was run as in [22]. 32P 
and 3H radioactivity in the immune complex of 
fibronectin was determined by scintillation coun- 
ting. 
In another experiment phosphorylation of fibro- 
nectin from 3 cell lines (GM0077, NIH/3T3, and 
NIL 8) was studied in quiescent vs rapidly growing 
cells after 4 h of labeling with [32P]orthophosphate 
and [3H]leucine. Table 1 shows that growing cells 
of all 3 cell lines had -3-7-fold higher 32P:3H ratio 
than quiescent cells. This increase in phosphoryla- 
tion of fibronectin may in part, but could not 
3. RESULTS AND DISCUSSION 
Fig. 1 shows a representative xperiment of the 
kinetics of phosphorylation of fibronectin in rela- 
tion to [3H]leucine incorporation in quiescent vs 
growing NIL 8 cells. At all time points the ratio of 
32P:3H in fibronectin was higher in growing, than 
in quiescent cells. Especially at earlier time points, 
i.e., 2 h and 4 h, the 32P:3H ratio in this experi- 
ment was 8-fold and 5-fold higher in growing cells 
than in quiescent cells. With increasing length of 
labeling period (8 h and 24 h) fibronectin from 
growing cells showed about 1.53-fold increase in 
entirely be due to increased uptake of [32P]ortho- 
phosphate by growing cells as the 32P:3H ratio in 
the cell-associated and secreted proteins after 4 h of 
labeling was only 1.3-2.4-fold higher in growing, 
than in quiescent cells. 
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Fig. 1. Kinetics of phosphorylation of fibronectin in 
relation to [‘Hlleucine incorporation: 2 x lo5 and 2 x lo4 
NIL 8 cells were seeded in 60 mm Petri dishes in 
DMEM with FCS. On day 4 cells were labeled with 
[32P]orthophosphate and [3H]leucine for indicated time 
periods (see section 2 for details of labeling conditions 
and isolation of fibronectin). 
Fig. 2. Electroporetic mobilities of fibronectin from 
quiescent, and growing NIL 8 cells. [32P]Orthophos- 
phate labeled fibronectin isolated from the conditioned 
medium of cells labeled for 4 h was run on 7% SDS- 
polyacrylamide gel: a quiescent cells; b growing cells. 
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Table 1 
Ratio of [32P]orthophosphate o [3H]leucine incorporation in fibronectin 
Cells 
GM0077 
growing 
GM0077 
quiescent 
NIH 3T3 
growing 
NIH 3T3 
quiescent 
NIL 8 
growing 
NIL 8 
quiescent 
Fibronectin Cell-associated proteinsa Secreted proteinsb 
32P :‘H Ratio of growing: 32P :‘H Ratio of growing: “P : 3H Ratio of growing: 
ratio quiescent cells ratio quiescent cells ratio quiescent cells 
0.823 6.94 2.26 
4.84 1.38 1.52 
0.170 5.01 1.48 
0.092 6.65 2.40 
3.06 2.13 2.40 
0.030 3.12 1.00 
0.061 7.49 1.83 
6.7 2.01 2.23 
0.009 3.72 0.82 
a Total trichloroacetic acid - insoluble counts of cell lysate 
b Total trichloroacetic acid - insoluble counts of the conditioned medium 
Cell-associated and secreted proteins: 2 x lo5 and 2 x 104 NIL 8 cells, and 3 x lo5 and 3 x lo4 NIH 3T3 cells were grown 
in DMEM + FCS for 4 days in 60 mm Petri dishes. For sparse GM0077 cells, 24 h before the labeling a confluent and 
quiescent monolayer in 60 mm dish was split at a 1:2 ratio. Labeling with [“PI-orthophosphate and [‘Hlleucine was 
for 4 h (see section 2 for details of labeling conditions and isolation of fibronectin) 
Phosphorylation of polypeptides has been shown 
to alter their electrophoretic and chromatographic 
mobilities [23-261. Fibronectin from transformed 
hamster cells, that had an increased level of phos- 
phorylation compared to the protein from normal 
cells, also showed a slower electrophoretic mobility 
in SDS gels [20]. The same is also true for fibro- 
nectin from growing cells. Fig. 2 shows a slower 
migration of fibronectin from growing NIL 8 cells 
than that from quiescent cells after a 4 h labeling 
period. In this particular experiment fibronectin 
from growing cells had an 8-fold increase in 32P:3H 
ratio compared to the fibronectin from quiescent 
cells. In other experiments using NIL 8 or other cell 
lines and different lengths of labeling periods 
where the increase in phosphorylation was only 
3-4-fold or less, the difference in electrophoretic 
mobility was not very obvious. 
It is clear from the results presented above that 
like the protein from transformed hamster cells, 
fibronectin from growing hamster cells is phos- 
phorylated to a higher extent than fibronectin from 
quiescent cells. In several experiments after a 4-h 
labeling period the 32P:3H ratio of fibronectin in 
actively growing cells was 5-lo-fold higher than 
the ratio in fibronectin from quiescent cells. An 
8-12-fold increase in 32P:3H ratio of fibronectin 
was reported for transformed NIL 8 hamster cells 
[20]. Furthermore, preliminary experiments showed 
that the 32P:3H ratio of fibronectin from the trans- 
formed hamster cell line NIL 8-HSV, was not 
significantly affected by its state of growth. The 
significance of these observations remain to be 
elucidated. 
In light of the importance of reversible phos- 
phorylation reactions of proteins as an index of 
their functional and regulatory activities [27,28] 
several laboratories have studied cell cycle associ- 
ated differences in activities of protein kinases. 
Differences have been found in the activities of 
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both CAMP-dependent and CAMP-independent 
nuclear and cytoplasmic protein kinases which 
vary with the state of phosphorylation of proteins 
during different growth stages [29-341. Phosphory- 
lation of fibronectin is a highly specific and con- 
served phenomenon [20] occurring only on serine 
residue(s) [20,35]. Information on the kinase(s) 
responsible for phosphorylation of fibronectin and 
on the involvement of the phosphorylated region, 
if any, in various functional aspects of fibronectin 
will contribute to a better understanding of how 
this important protein functions at the cell surface 
and in blood plasma. 
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